TECHNOLOGY FOCUS - ORGANIC CHEMISTRY - Preparation: No general preparation is given. Preferred Compound: The amino anthracene derivative (I) is preferably of formula (II).R11,R12=R1.Preferred Layer: The light emitting layer further contains anthracene derivative of formula (III). The content of amino anthracene derivative (I) in the light emitting layer is 0.1-20 wt.%R101-R108=1-10C alkyl, 3-10C cycloalkyl, 3-30C alkylsilyl, 8-30C aryl silyl, 1-20C alkoxy, 6-20C aryloxy, 6-30C aryl, 5-30C heterocyclyl (all optionally substituted), H or fluoro;andAr12,Ar13=6-30C aryl or 5-30C heterocyclyl (both optionally substituted). Preferred Definitions:    Ar1-Ar3=group (iii);and    X=O.    SPECIFIC COMPOUNDS - 150 Amino anthracene derivatives (I) e.g. 2-N,6-N-bis((8-oxatricyclo(7.4.0.02,7)trideca-1(9),2,4,6,10,12-hexaen-6-yl))-2-N,6-N-diphenyl-9,10-bis(4-phenylphenyl)-9,10-dihydroanthracene-2,6-diamine of formula (IA), 2-N,6-N-bis((8-oxatricyclo(7.4.0.02,7)trideca-1(9),2(7),3,5,10,12-hexaen-6-yl))-2-N,6-N,9,10-tetraphenylanthracene-2,6-diamine, 2-N,6-N-bis(naphthalen-2-yl)-2-N,6-N-bis((8-oxatricyclo(7.4.0.02,7)trideca-1(9),2(7),3,5,10,12-hexaen-6-yl))-9,10-diphenylanthracene-2,6-diamine, 2-N,6-N-bis(naphthalen-1-yl)-2-N,6-N-bis((8-oxatricyclo(7.4.0.02,7)trideca-1(9),2(7),3,5,10,12-hexaen-6-yl))-9,10-diphenylanthracene-2,6-diamine and 2-N,6-N-bis((8-oxatricyclo(7.4.0.02,7)trideca-1(9),2(7),3,5,10,12-hexaen-6-yl))-9,10-diphenyl-2-N,6-N-bis(4-phenylphenyl)anthracene-2,6-diamine are disclosed.    EXAMPLE - 2,6-Bis((8-oxatricyclo(7.4.0.02,7)trideca-1(9),2,4,6,10,12-hexaen-6-yl(phenyl)amino))-9,10-bis(4-phenylphenyl)-9,10-dihydroanthracene-9,10-diol (in g) (5.9), potassium iodide (2.4), sodium phosphinate monohydrate (760 mg) and acetic acid (100 ml) were refluxed for 6 hours, and methanol was added to the obtained reaction mixture to obtain a crude product. The obtained crude product was refined by silica gel chromatography, and obtained solid was washed and dried under reduced pressure to obtain 2-N,6-N-bis((8-oxatricyclo(7.4.0.02,7)trideca-1(9),2,4,6,10,12-hexaen-6-yl))-2-N,6-N-diphenyl-9,10-bis(4-phenylphenyl)-9,10-dihydroanthracene-2,6-diamine (IA) (1.1 g).